Fondazione Irccs Ca' Granda, Ospedale Maggiore Policlinico
Clinical trials sponsored by Fondazione Irccs Ca' Granda, Ospedale Maggiore Policlinico, explained in plain language.
-
Cancer drug combo tested for rare skin cancer – but study never started
Disease control TerminatedThis study aimed to test a combination of two drugs, pembrolizumab and lenvatinib, in people with classic Kaposi sarcoma that had not responded to prior chemotherapy. The goal was to see if the combination could shrink tumors better than standard chemotherapy. However, the study …
Phase: PHASE2 • Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
Which hormone combo do women with endometriosis like best?
Symptom relief OngoingThis study looks at two different hormone treatments for endometriosis, a condition that causes pain and fertility problems. About 138 women who have been on one of two hormone combinations for at least 6 months will report how satisfied they are with their therapy. The goal is t…
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Symptom relief
Last updated Apr 30, 2026 15:50 UTC
-
Massive hospital study tracks kidney injury rates in 43,000 patients
Knowledge-focused OngoingThis study looks at how often acute kidney injury (AKI) happens in people while they are in the hospital. Researchers will review medical records of 43,000 patients to find out how common AKI is, which hospital units have the most cases, and how AKI affects recovery and survival.…
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated May 01, 2026 16:00 UTC